Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joshua S. Prince currently holds 15,249 shares of Vistagen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua S. Prince has been a net neutral trader of VTGN stock. They have purchased $0 and sold $0 worth of shares.
Joshua S. Prince's most recent insider trade was on Dec 31, 2025, when they sold 4,386 shares at $0.56 per share.
Joshua S. Prince serves as Executive at Vistagen Therapeutics, Inc. (VTGN). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Joshua S. Prince holds the position of Executive at Vistagen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Joshua S. Prince has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Joshua S. Prince was on Jun 30, 2025, when they purchased $8.3K worth of VTGN shares. This transaction involved 4,882 shares at $1.70 per share.
Joshua S. Prince currently owns 15,249 shares of Vistagen Therapeutics, Inc. (VTGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joshua S. Prince's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joshua S. Prince has 4 Form 4 filings on record as an insider at Vistagen Therapeutics, Inc..
Set alerts for Joshua S. Prince and 40,000+ other insiders.